Nektar Therapeutics (NKTR)
43.88
-0.58
(-1.32%)
USD |
NASDAQ |
Dec 24, 12:59
43.88
0.00 (0.00%)
After-Hours: 13:59
Nektar Therapeutics SG&A Expense (TTM): 74.62M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Owlet, Inc. | 49.64M |
| Amgen, Inc. | 6.976B |
| Apyx Medical Corp. | 22.16M |
| Rigel Pharmaceuticals, Inc. | 115.43M |
| Zevra Therapeutics, Inc. | 73.39M |